NSRX Nasus Pharma Ltd.: Net earnings per share for the last 12 months

Nasus Pharma Ltd (NSRX) - corporate logo

The market price visualization of EPS (TTM) for Nasus Pharma Ltd (NSRX) demonstrates a figure of 0.00. Business stability relies on regulatory approvals and the success of tests for treatments against viral infections and overdoses. B2B contracts and the implementation of unique nasal drug delivery methods drive positive momentum. Despite its narrow specialization in emergency airway protection, Nasus Pharma Ltd (NSRX) successfully monetizes its developments through retail pharmacies.

NSRX: Nasus Pharma Ltd Net earnings per share (EPS TTM) 11/23/2025 - 11/18/2026

Financial and market metric breakdowns for Nasus Pharma Ltd (NSRX)

- current price and projected stock value:
Initial company analysis:NSRX (Nasus Pharma Ltd)
Original product of Nasus Pharma, Ltd.

This indicator measures the net profit per share dynamics over the last twelve months, allowing investors to filter out market noise and assess the actual efficiency of capital generation. By analyzing the current EPS YoY TTM growth rate, one can compare market volatility with the results of the Nasus Pharma (NSRX) pharmaceutical team's efforts to monetize intellectual property and implement its technological platforms.

Direct competitors

Earnings per share for the trailing year INDV (Indivior plc)|Collegium Corp (COLL) - Earnings per share for the last twelve months|Net earnings per share for the last 12 months Cronos|CGC (Canopy Growth Corp.) - Net earnings per share (EPS TTM)|HITI: Earnings per share for the trailing year|Earnings per share for the last twelve months Aurora Cannabis, Inc. (ACB)|Net earnings per share for the last 12 months Achieve Life Sciences, Inc. ACHV|skyebioscience.com - Net earnings per share for the last 12 months|Anebulo (ANEB) - Net earnings per one share for the last twelve months|Canndoc - Net earnings per share (EPS TTM)|Earnings per share for the trailing year NTRB (nutriband.com)|IGC: Net earnings per share (EPS TTM)|MIRA Pharma - Earnings per share for the trailing year|Net earnings per share for the last 12 months FLGC|Earnings per share for the last 12 months IMCC (imcannabis.com)|Earnings per share for the last twelve months adialpharma.com (ADIL)|ARTL (Artelo Biosciences, Inc.) - Earnings per share for the trailing year|Ensysce Biosciences - Net earnings per share for the last 12 months|Earnings per share for the trailing year TTNP|gnln.com - Net earnings per share (EPS TTM)|Earnings per share for the trailing year INM (InMed)|Akanda Corp. (AKAN) - Earnings per share for the last twelve months|ENVB - Net earnings per share for the last four quarters|BGXX (Bright Green Corp.) - Net earnings per share (EPS TTM)|Net earnings per one share for the last twelve months Hempacco Co., Inc. HPCO